Leerink Maintains Outperform on Cardinal Health, Inc. (CAH) March 2026

NodeGuardian · 2026-03-10T03:21:51+00:00

Leerink Partners has reiterated an Outperform rating for Cardinal Health, Inc. (CAH) as of March 9, 2026, reflecting confidence in its growth prospects, while Meyka AI rates CAH with a B+ grade based on financial performance.

NodeGuardian

2026-03-10 03:21:51

Abstract generation in progress

Leerink Partners has maintained an Outperform rating on Cardinal Health, Inc. (CAH) as of March 9, 2026, signaling continued confidence in the company’s fiscal second-half 2026 growth prospects. This reaffirmation, following a presentation at the Leerink Global Healthcare conference, caused a modest market reaction with no new price target issued. Meyka AI currently rates CAH with a B+ grade, factoring in various financial and market performance metrics.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.